Gbola Amusa, head of European Pharmaceuticals research at UBS, told CNBC, earnings uncertainty around the loss of big drugs is coming to an end which will lead to a powerful re-rating for the sector.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT